Applying the ASRA guidelines to the use of low-molecular-weight heparin thromboprophylaxis in major orthopedic surgery

Journal of Arthroplasty

Volumn 19, Issue 7, 2004, Pages 919-922

  O'Rourke, Michael R ^a,b   Rosenquist, Richard W ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

American Society of Regional Anesthesia guidelines; low molecular weight heparin; neuraxial and regional anesthesia; orthopedic surgery; postoperative regional analgesia; thromboprophylaxis

Indexed keywords

ANESTHETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANALGESIA; ARTICLE; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG SAFETY; HUMAN; MEDICAL SOCIETY; NERVE FIBER; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PROPHYLAXIS; REGIONAL ANESTHESIA; SIDE EFFECT; SPINAL CORD HEMORRHAGE; STATISTICAL SIGNIFICANCE; THROMBOSIS;

ANALGESIA; ANESTHESIA, CONDUCTION; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; ORTHOPEDICS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; TIME FACTORS; VENOUS THROMBOSIS;

EID: 4644260048     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2004.03.015     Document Type: Article

References (10)

1. Colwell C.W. Jr, Collis D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am. 81:1999;932
2. Hull R.D., Pineo G.F., Francis C., et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison: The North American Fragmin Trial Investigators. Arch Intern Med. 160:2000;2199
3. Horlocker T.T., Wedel D.J., Benzon H., et al. Regional anesthesia in the anticoagulated patient defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 28:2003;172
4. Tryba M., Wedel D.J. Central neuraxial block and low molecular weight heparin (enoxaparine) lessons learned from different dosage regimes in two continents. Acta Anaesthesiol Scand. 41:1997;100
5. Lumpkin M.M. FDA public health advisory. Anesthesiology. 88:1998;27A
6. Horlocker T.T., Wedel D.J. Neuraxial block and low-molecular-weight heparin balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med. 23:(suppl 2):1998;164
7. Ljungstroem K.G. Editorial on LMWH and regional anaesthesia - dangerous recommendations. Acta Anaesthesiol Scand. 43:1999;116
8. Bergqvist D., Maetzsch T., Burmark U.-S., et al. Low molecular weight heparin given in the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg. 75:1988;888
9. Bergqvist D., Wu C.L., Neal J.M. Anticoagulation and neuraxial regional anesthesia perspectives. Reg Anesth Pain Med. 28:2003;163
10. Rodgers A., Walker N., Schug S., et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia results from overview of randomised trials. Br Med J. 321:2000;1